New From the FASEB Journal: Snap Reverses Chemotherapy Resistance in Human Tumor Cells Through Downregulation of MGMT
Posted on: November 14, 2019
FASEB Encourages Negotiations to Finish the FY 2020 Budget
Posted on: November 13, 2019
FASEB Endorses the American Cures Act and the American Innovation Act
Posted on: November 13, 2019
FASEB Submits Comments to OSTP on U.S. Bioeconomy
Posted on: October 24, 2019
FASEB Submits Feedback on NIH Interim Recommendations to Prevent Sexual Harassment
Posted on: October 3, 2019
FASEB Issues Letter to NIH OLAW on Administrative Burden Report
Posted on: October 2, 2019
FASEB Statement on EPA's Directive to Reduce Mammalian Studies
Posted on: September 27, 2019
New From The FASEB Journal: PML as Potential Treatment for Pancreatic Cancer
Posted on: September 26, 2019
Review Series in The FASEB Journal Provides Insight into Alzheimer’s Disease
Posted on: September 24, 2019
New From The FASEB Journal: IGF1 Gene is Essential to Adult Tendon Growth, Animal Study Shows
Posted on: September 20, 2019
New From the FASEB Journal: Anesthetic Drug Sevoflurane Improves Sepsis Outcomes, Animal Study Reveals
Posted on: September 12, 2019
FASEB Joins National Organizations in Urging Federal Agencies to Balance Security Concerns with Impact on Scientific Collaborations
Posted on: September 10, 2019
New From The FASEB Journal: Novel Study Reveals Presence of Fungal DNA in the Fetal Human Gut
Posted on: September 5, 2019
FASEB Comments on Implementation of Administration's Human Fetal Tissue Policy
Posted on: September 4, 2019
FASEB Statement on Graduate Student Savings Act
Posted on: September 3, 2019

Page: 1 of 11
Page Size: